<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02763423</url>
  </required_header>
  <id_info>
    <org_study_id>NJGYNFM-SC-02</org_study_id>
    <nct_id>NCT02763423</nct_id>
  </id_info>
  <brief_title>Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis</brief_title>
  <acronym>UCMSCDKA</acronym>
  <official_title>The Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation to Treat New-onset Type 1 Diabetes With Diabetic Ketoacidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase II trial in individuals who have been diagnosed with type 1 diabetes within
      the previous 12 months and suffered from diabetic ketoacidosis at onset of disease. The
      purpose of this study is to determine whether allogeneic umbilical cord mesenchymal stem cell
      transplantation is effective in the treatment of patients with severe type 1 diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the clinical efficacy of allogeneic umbilical cord mesenchymal stem cell
      transplantation in the treatment of patients with severe type 1 diabetes, defined as with the
      history of diabetic ketoacidosis from diagnosis. All the patients are intravenously
      administrated with single-dose or double-dose umbilical cord mesenchymal stem cell and
      followed up for 36 months. Clinical and laboratory manifestations are compared before and
      after transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from baseline exogenous insulin dose at different time points post treatment</measure>
    <time_frame>1 month, 3 months,6 months, 12 months, 24 months, 36 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>C-peptide level</measure>
    <time_frame>1 month, 3 months, 6 months, 12 months, 24 months, 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c level</measure>
    <time_frame>1 month, 3 months, 6 months, 12 months, 24 months, 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>titres of islet antigen antibodies</measure>
    <time_frame>1 month, 3 months, 6 months, 12 months,24 months, 36 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ketoacidosis, Diabetic</condition>
  <arm_group>
    <arm_group_label>umbilical cord mesenchymal stem cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single- or double-dose intravenous injection of umbilical cord mesenchymal stem cells for the treatment of severe type 1 diabetes patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>umbilical cord mesenchymal stem cell</intervention_name>
    <description>allogeneic umbilical cord mesenchymal stem cell transplantation by intravenous injection</description>
    <arm_group_label>umbilical cord mesenchymal stem cell</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes

          -  Duration of disease less than 12 months from diagnosis

          -  With the history of diabetic ketoacidosis

        Exclusion Criteria:

          -  Pregnancy

          -  Severe psychiatric disorder

          -  Severe organic impairment(renal,hepatic,cardiac,pulmonary)

          -  Active infectious disease

          -  Previous or present neoplastic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dalong Zhu, MD.PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dalong Zhu, MD.PhD.</last_name>
    <phone>86-25-83106666</phone>
    <phone_ext>61430</phone_ext>
    <email>zhudalong@nju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dalong Zhu, MD.PhD.</last_name>
      <phone>86-25-83106666</phone>
      <phone_ext>61430</phone_ext>
      <email>zhudalong@nju.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Jing Lu, PhD.</last_name>
      <phone>86-25-83106666</phone>
      <phone_ext>61431</phone_ext>
      <email>qiusnow16@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>May 4, 2016</last_update_submitted>
  <last_update_submitted_qc>May 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</investigator_affiliation>
    <investigator_full_name>Dalong Zhu</investigator_full_name>
    <investigator_title>Chief Physician, Professor, Director of Endocrinology Department</investigator_title>
  </responsible_party>
  <keyword>umbilical cord stem cell</keyword>
  <keyword>diabetic ketoacidosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Ketosis</mesh_term>
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Diabetic Ketoacidosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

